Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria vaccines.

D M Gordon1

  • 1Department of Immunology, Walter Reed Army Institute of Research, Washington, DC.

Infectious Disease Clinics of North America
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Developing an effective malaria vaccine is crucial due to widespread disease and drug resistance. Research focuses on Plasmodium falciparum, but insights benefit vaccines for all human malaria species.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colony life history of the tropical arboreal ant, <i>Cephalotes goniodontus</i> De Andrade, 1999.

Insectes sociaux·2024
Same author

Harvester ant colonies differ in collective behavioural plasticity to regulate water loss.

Royal Society open science·2023
Same author

Genetic relationships among rhizopine-producing <i>Rhizobium</i> strains.

Microbiology (Reading, England)·2021
Same author

Cellular conditions that modulate the fungicidal activity of occidiofungin.

Journal of applied microbiology·2017
Same author

Two lineages that need each other.

Molecular ecology·2017
Same author

The behavioral ecology of variation in social insects.

Current opinion in insect science·2016
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Immunology
  • Parasitology
  • Vaccinology

Background:

  • Malaria remains a significant global health challenge.
  • Increasing drug resistance necessitates novel control strategies.
  • Advances in understanding the parasite and immune response are driving vaccine development.

Purpose of the Study:

  • To summarize progress in developing an effective malaria vaccine.
  • To highlight the focus on Plasmodium falciparum due to its high impact.
  • To emphasize the broader applicability of research findings to other malaria species.

Main Methods:

  • Review of recent advances in malaria research.
  • Analysis of immune mechanisms against various parasite life cycle stages.
  • Focus on Plasmodium falciparum vaccine development.

Related Experiment Videos

Main Results:

  • Significant progress has been made toward an effective malaria vaccine.
  • Vaccine strategies aim to target multiple stages of the parasite's life cycle.
  • Research on Plasmodium falciparum is informing efforts against other species.

Conclusions:

  • An effective malaria vaccine is a major goal in medical science.
  • Targeting Plasmodium falciparum is a priority due to resistance and fatality rates.
  • Knowledge gained from P. falciparum research is transferable to P. vivax, P. malariae, and P. ovale vaccine development.